Flu Infection at UPHS
ConditionInfluenza Human
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Aged 18 years and older
Influenza positive test result performed within the University of Pennsylvania Health System
Disqualifiers
Known latex allergy
Immunosuppression as a result of an underlying illness or treatment with immunosuppressive or cytotoxic drugs, or use of anticancer chemotherapy or radiation therapy within the preceding 36 months
Pregnancy due to the volume of blood collected in this study
Treatment with immunoglobulin or another blood product within the 3 months prior to enrollment in this study
Trial design
Treatments tested in this trial
- influenza virus infection
Treatment groups
No treatment groups listed
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Stanford University
Collaborator
Source ClinicalTrials.gov